SPONSOR
Chunrui Li
Total Trials
1
Recruiting
1
Phases
EARLY_Phase 1
Conditions studied: Relapsed/ Refractory Multiple Myeloma
Chunrui Li is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Relapsed/ Refractory Multiple Myeloma.
The trial portfolio spans EARLY_Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Chunrui Li
How many clinical trials has Chunrui Li sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Chunrui Li, of which 1 are actively recruiting participants. These trials cover conditions including Relapsed/ Refractory Multiple Myeloma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Chunrui Li research focus on?
Chunrui Li clinical trials span Relapsed/ Refractory Multiple Myeloma. The research pipeline includes EARLY_Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Chunrui Li clinical trial?
To participate in a Chunrui Li trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Chunrui Li trials with current recruitment status updated daily.
Clinical Trials by Chunrui Li
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology